FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

ANDA Withdrawal Notice Corrected

Federal Register notice: FDA corrects a 3/9 notice that announced the withdrawal of approval of 16 ANDAs abbreviated from multiple applicants.

Human Drugs

4 Unapproved Homeopathic Injectable Manufacturers Warned

FDA warns four manufacturers of unapproved injectable drugs labeled as homeopathic.

Biologics

CGMP Deviations at Fenwal International

FDA warns Fenwal International about CGMP deviations in manufacturing the firms blood-pack units with and without in-line leukoreduction filters, as w...

Appeals Court Backs Rejection of Rule on Drug Price Ads

The DC Appeals Court affirms the DC federal courts rejection of an HHS rule requiring drug companies to include the wholesale acquisition price of som...

Human Drugs

FDA Approves Jazz Zepzelca for Some Lung Cancers

FDA says it approved Jazz Pharmas Zepzelca for treating some small cell lung cancer cases.

Biologics

Lilly BLA for Insulin Lispro Approved

FDA approves an Eli Lilly BLA for Lyumjev (insulin lispro-aabc) injection, a new rapid-acting insulin indicated to improve glycemic control in adults ...

Medical Devices

Endologix Recalls Ovation iX Abdominal Stent Graft

Endologix recalls the Ovation iX Abdominal Stent Graft System due to risks of liquid polymer leaks during implantation.

Human Drugs

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that includes Cosmaceutical Research Lab, Fenwal International, Klarity Medical Products, and Takeda ...

Human Drugs

CGMP Issues Cited in Takeda Inspection

FDA warns Takeda about CGMP violations at its drug manufacturing facility in Yamaguchi, Japan.

Human Drugs

Guide on Collecting Patient Experience Data

FDA makes available a guidance entitled Patient-Focused Drug Development: Collecting Comprehensive and Representative Input.